Juho Jalkanen - University of Turku | 人才画像

基本信息

Career Trajectory

Bio

I am a clinician by background, but to understand diseases we need sophisticated molecular science. I work in the cross talk of clinical medicine and molecular level research. My interests include hypoxia, vascular damage, atherosclerosis, cytokines and macrophage plasticity.

Research Interests

Papers共 58 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Bexmarilimab Plus Azacitidine for High-Risk Myelodysplastic Syndrome and Relapsed or Refractory Acute Myeloid Leukaemia: Results from the Dose-Escalation Part of a Multicentre, Single-Arm, Phase 1/2 Trial

Mika Kontro, Anthony Selwyn Stein, Marja Pyörälä,Johanna Rimpiläinen,Timo Siitonen, Arno Ylitalo,Marie-Louise Fjällskog,Juho Jalkanen, Sofia Aakko, Inka Pawlitzky,Maija Hollmén,Naval Daver

The Lancet Haematology (2025)

Cited0Views0WOSBibtex

Association Between Aortic Calcification and Cytokine Levels in Patients with Peripheral Artery Disease

Ville Rantasalo,Dan Laukka,Veikko Nikulainen,Juho Jalkanen,Jarmo Gunn,Tuomas Kiviniemi,Harri Hakovirta

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 10 (2024)

Cited0Views0WOSBibtex

Unveiling the Impacts of FDA Breakthrough Therapy Designation: a Dual-Perspective Examination of Economic and Developmental Outcomes for Biotechnology Companies

Joab Williamson,Alexander James Spicer, Elina Louramo,Juho Jalkanen

Drug Discovery Todayno. 4 (2024): 103919-103919

Cited0Views0WOSBibtex

Differential Circulating Cytokine Profiles in Acute Coronary Syndrome Versus Stable Coronary Artery Disease

Eveliina Maaniitty,Juho Jalkanen,Sami Sinisilta,Jarmo Gunn,Tuija Vasankari,Fausto Biancari,Sirpa Jalkanen,K. E. Juhani Airaksinen,Maija Hollmen,Tuomas Kiviniemi

Scientific Reportsno. 1 (2024)

Cited0Views0WOSBibtex

Transcriptomic and Spatial Dissection of Human Ex Vivo Right Atrial Tissue Reveals Proinflammatory Microvascular Changes in Ischemic Heart Disease

Cell Reports Medicineno. 5 (2024): 101556-101556

Cited1Views0WOSBibtex

QClus: A Droplet-Filtering Algorithm for Enhanced Snrna-Seq Data Quality in Challenging Samples

Eloi Schmauch, Johannes Ojanen,Kyriakitsa Galani,Juho Jalkanen, Kristiina Harju,Maija Hollmen,Hannu Kokki,Jarmo Gunn,Jari Halonen,Juha Hartikainen,Tuomas Kiviniemi,Pasi Tavi,Minna U. Kaikkonen,Manolis Kellis,Suvi Linna-Kuosmanen

NUCLEIC ACIDS RESEARCH (2024)

Cited1Views0WOSBibtex

Distinct Circulating Cytokine Levels in Patients with Angiography-Proven Coronary Artery Disease Compared to Disease-Free Controls

Eveliina Maaniitty,Sami Sinisilta,Juho Jalkanen,Tuija Vasankari,Fausto Biancari,Jarmo Gunn,Sirpa Jalkanen,K. E. Juhani Airaksinen,Maija Hollmen,Tuomas Kiviniemi

International Journal of Cardiology Cardiovascular Risk and Prevention (2024): 200307-200307

Cited0Views0WOSBibtex

Abstract A14: Ex Vivo Immune Activation with the Macrophage-Targeting Immunotherapy, Anti-Clever-1 Antibody Bexmarilimab, in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Arno Ylitalo,Sofia Aakko,Heikki Kuusanmäki,Mari Björkman,Juho Jalkanen,Marie-Louise Fjällskog,Caroline Heckman,Maija Hollmén,Mika Kontro

Blood Cancer Discoveryno. 3_Supplement (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn